Seaport Therapeutics raised $225 million in a Series B round led by General Atlantic to advance its clinical-stage pipeline of neuropsychiatric medicines.
Amount Raised
$225 Million
Round Type
Series B
BostonBiotechnologyTherapeuticsPharmaceuticalBiopharmaInvestors
Description
Seaport Therapeutics announced the closing of an oversubscribed $225 million Series B financing round, bringing total capital raised to $325 million since its launch. The company will use the funds to further its clinical-stage pipeline and enhance its Glyph™ technology platform.
Quick answer
Seaport Therapeutics raised $225 Million in a Series B round, dated October 21, 2024. Investors: General Atlantic, T. Rowe Price Associates, Inc., PureTech Health, Third Rock Ventures, Sofinnova Investments, T. Rowe Price Associates, Foresite Capital and Invus. Seaport Therapeutics is based in Boston, Massachusetts, United States.
- How much did Seaport Therapeutics raise?
- Seaport Therapeutics raised $225 Million in a Series B round on October 21, 2024.
- Who invested in Seaport Therapeutics?
- General Atlantic, T. Rowe Price Associates, Inc., PureTech Health, Third Rock Ventures, Sofinnova Investments, T. Rowe Price Associates, Foresite Capital and Invus are named as investors in this round.
- What does Seaport Therapeutics do?
- Seaport Therapeutics is a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs.
- Where is Seaport Therapeutics based and how big is it?
- Seaport Therapeutics is based in Boston, Massachusetts, United States.
- Who are the decision-makers at Seaport Therapeutics?
- Fundz holds 1 contact at Seaport Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Seaport Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Bio Green Med Solution, Inc. raised $2.1M (Seed) on November 14, 2024.
- Ensho Therapeutics raised $5M on October 24, 2024.
- SystImmune raised $7.9M on October 18, 2024.
- OnKure Therapeutics raised $65M on October 4, 2024.
- Clene Nanomedicine raised $7.3M on October 1, 2024.
- PhoreMost raised $12M (Series B) on September 10, 2024.
Who to call at Seaport Therapeutics, and when
A new round usually means Seaport Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Seaport Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Seaport Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Seaport Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Seaport Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSeaport Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.